News

The Aligning Science Across Parkinson’s Initiative (ASAP) has awarded a grant to Sascha Martens’ group and scientists from the University of…

17 Sep'20

Eveliqure Biotechnologies GmbH announced the award of a US government contract from the National Institute of Allergy and Infectious Diseases (NIAID),…

17 Sep'20

CEBINA GmbH announced further positive results in its collaborative COVID-19 drug repurposing project, demonstrating that a common allergy nasal spray…

15 Sep'20

A new role for Casein Kinase-1 on RNF43 is identified – Study by Tadasuke Tsukiyama and IMBA – Institute of Molecular Biotechnology of the Austrian…

14 Sep'20

Valneva announced a vaccine partnership with the UK government for its inactivated COVID-19 vaccine, VLA2001.

09 Sep'20

Since 1947, the City of Vienna honours residents distinguished in a range of disciplines with the “Preis der Stadt Wien” awards for their life…

09 Sep'20

Valneva announced the signing of a new contract, lasting up to three years, with the U.S. government Department of Defense (DoD) for the supply of its…

08 Sep'20

Valneva announced the initiation of a pivotal Phase 3 clinical trial for its differentiated, single-shot chikungunya vaccine candidate VLA1553. The…

07 Sep'20

LifeTime, which counts Jürgen Knoblich, scientific director at IMBA, as a leading member, has developed a strategy to integrate…

04 Sep'20

The IMP is one of thirteen European institutions participating in the four-year project ‘Deconstructing the evolution of metastasis’ (Evomet).

04 Sep'20

Autophagy, from the Greek for ‘self-eating’, is an essential process that isolates and recycles cellular components under conditions of stress or when…

03 Sep'20

The European Research Council (ERC) has selected Clemens Plaschka's research for funding under the Horizon 2020 Excellent Science scheme.

Investigating Parkinson’s through the lens of autophagy - ASAP grant for Sascha Martens

Eveliqure announces the award of a NIAID contract to finance Phase 2 clinical studies of its combined Shigella and ETEC vaccine candidate

CEBINA reports positive findings on the potency of azelastine, a widely used antihistamine, as anti-COVID-19 approach

The Wnt pathway gets even more complicated

Valneva Announces Major COVID-19 Vaccine Partnership with U.K. Government

City of Vienna honours Meinrad Busslinger

Valneva Announces New IXIARO® Supply Contract with the US Government worth up to $166 million

Valneva Initiates Phase 3 Clinical Study for its Chikungunya Vaccine Candidate VLA1553

IMBA is lead participant in a new, cell-based medicine initiative for Europe

Evomet – a project to train future leaders in metastasis research

Autophagy: the beginning of the end

ERC Starting Grant awarded to Clemens Plaschka of IMP